Wilmington, Delaware, United States, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Industry players concur that there is an unmet need for effective therapeutics for managing epilepsy and its comorbidities. To address the need, they are geared toward developing therapeutics for drug-resistant epilepsy and drugs with less adverse reactions and fewer drug interactions. The value of the global epilepsy therapeutics market was pegged at US$ 10.6 Bn in 2021.
Understanding the etiology is shaping modern approaches to epilepsy management, and has also enriched the prospects of epilepsy therapeutics market size. Increase in incidences of head injury, brain tumors, strokes, and brain infections has led to increased incidence of epilepsy. Strokes for instance is a prevalent etiology in adults with new-onset epilepsy. Advancements in diagnostic technologies has led to better identification of epilepsy syndrome, including rare and severe forms of epilepsy, reiterates ongoing epilepsy therapeutics market trends.
A recent epilepsy therapeutics market forecast finds that anti-epileptic drugs (AEDs) are still a markedly lucrative segment in the global epilepsy therapeutics market. Of note, new generation of these drugs have demonstrated promising outcomes in reducing the prevalence of drug-resistant epilepsy. Of note, the study authors found that the prevalence of post-traumatic epilepsy (PTE) and post-traumatic seizure (PTS) underpins massive profitable avenues.
Get Exclusive PDF Sample Copy of Epilepsy Therapeutics Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2448
Key Findings of Epilepsy Therapeutics Market Study
- Non-Invasive Therapeutic Strategies Gain Patient Acceptance, Generating Revenues: Oral is the most preferred route of administration, particularly as they are non-invasive. The need for minimally invasive routes of administration is opening up new possibilities in the epilepsy therapeutics market. Advances in therapeutic strategies has brought intravenous routed to the center-stage. The segment is replete with opportunities. Rise in demand for effective analgesic drugs is invigorating growth of the segment, found the study.
- Demand for Second Generation Epilepsy Therapeutics Underpins Vast Lucrative Avenue: First generation epilepsy therapeutics are extensively commercialized in key markets. It thus held a key share in the epilepsy therapeutics market. On the other hand, enormous developments have been made to overcome the limitations of first-generation therapeutics. This has resulted in rapid emergence of second-generation segment. Indeed, the products in the segment have been found to gain better patient acceptance due to benefits of reduced drug-drug interactions, better tolerability than older agents, and their favorable effects on treating drug-resistant epilepsy.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=2448
Epilepsy Therapeutics Market Study: Key Drivers
- Growing awareness about the alarming public health burden of epilepsy—one of the most common chronic neurological disorders affecting world population of all ages—is a key factor anchoring the development of the epilepsy therapeutics market. Stridently, spreading awareness about how to improve quality of life of people of epilepsy community has led to reduced burden of stigmatization, thereby boosting the market outlook.
- The disease is associated with substantial comorbidities arising from epileptic seizures. Continuous research in antiepileptic drugs (AEDs) have helped reduce seizures and treat symptoms, recent developments in the epilepsy therapeutics suggest.
Epilepsy Therapeutics Market Study: Regional Growth Dynamics
- North America held a key share of the global epilepsy therapeutics market in 2021. Extensive research on various generations of AEDs has propelled the revenue prospects. The market has also been witnessing new revenue streams on the back of public education and awareness of the economic and health burden of the seizures. The U.S. accounted for a major share of the regional market.
- Opportunities in the Asia Pacific epilepsy therapeutics market are anticipated to rise at promising growth rate in the next few years. Substantial advancement in medical infrastructure, along with growing awareness about the impacts of epilepsy on the quality of life of the affected, is boosting the prospects.
Epilepsy Therapeutics Market Study: Key Players
Some of the key players in the market are Amneal Pharmaceuticals LLC, Upsher-Smith Laboratories, LLC, Eisai Co., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Novartis AG, Bausch Health Companies Inc., UCB S.A., and Pfizer, Inc.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2448
Epilepsy Therapeutics Market Study Segmentation
- Product
- First Generation Epilepsy Therapeutics
- Second Generation Epilepsy Therapeutics
- Third Generation Epilepsy Therapeutics
- Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Countries
- U.S.
- Canada
- Germany
- U.K.
- France
- Italy
- Russia
- Spain
- Rest of Europe
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- GCC Countries
- South Africa
- Israel
- Rest of Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Post-operative Pain Therapeutics Market: The global post-operative pain therapeutics market is anticipated to reach more than US$ 22.3 Bn by the end of 2031 with a CAGR of 5.7% from 2022 to 2031.
Joint Pain Injections Market: The global joint pain injections market is anticipated to reach more than US$ 9.8 Bn by the end of 2031 with a CAGR of 7.8% from 2022 to 2031.
Water for Injection Market: The global water for injection market is anticipated to reach more than US$ 53.8 Bn by the end of 2031 with a CAGR of 9.5% from 2022 to 2031.
Venous Diseases Treatment Market: The global venous diseases treatment market is anticipated to reach more than US$ 11.3 Bn by 2031 with a CAGR of 6.8% from 2022 to 2031.
Empty Capsules Market: The global empty capsules market is anticipated to reach more than US$ 4.5 Bn by the end of 2031 with a CAGR of 7.6% from 2022 to 2031.
Bruise Treatment Market: The global bruise treatment market is anticipated to reach more than US$ 444 Mn by the end of 2031 with a CAGR of 3.5% from 2022 to 2031.
Substance Abuse Treatment Market: The global substance abuse treatment market is anticipated to cross US$ 23.1 Bn by 2031 with a CAGR of 8.5% from 2022 to 2031.
Albumin (as Excipient) Market: The global albumin (as excipient) market is anticipated to reach more than US$ 1.7 Bn by the end of 2031 with a CAGR of 6.3% from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
